日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Portable electrochemical impedance biosensing with DRT-enabled machine learning for detecting E. coli O157:H7 in poultry meat

便携式电化学阻抗生物传感结合DRT机器学习技术检测禽肉中的大肠杆菌O157:H7

Tian, Yang; Liu, Ziyu; Pallerla, Chaitanya; Mahmoudi, Siavash; Bist, Ramesh Bahadur; Xiao, Yiting; Howell, Terry; Subbiah, Jeyamkondan; Wang, Dongyi

Adamantane-thiazole hybrids and related derivatives: synthesis, crystal structures, in vitro antibacterial, antifungal, and anti-proliferative activities

金刚烷-噻唑杂合物及其相关衍生物:合成、晶体结构、体外抗菌、抗真菌和抗增殖活性

El-Monaem, Heidi S Abd; El-Ashmawy, Mahmoud B; Abdel-Aziz, Naglaa I; Blacque, Olivier; Habib, E; Thamotharan, Subbiah; El-Emam, Ali A

Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study

纳洛昔醇(一种口服外周作用阿片受体拮抗剂)与一线全身治疗联合用于晚期肺腺癌(Alliance A221504):一项可行性和安全性研究

Gupta, Pankaj; Gupta, Kalpna; Dockter, Travis; Harlos, Elizabeth; Chow, Selina; Subbiah, Niveditha; Ruddy, Kathryn J; Bazhenova, Lyudmila; Terstriep, Shelby; Huang, Chao H; Kratzke, Robert A; Vokes, Everett E; Loprinzi, Charles L

Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective

分子引导的精准肿瘤学在原发灶不明癌症中的应用:最新进展

Subbiah, Vivek; Rassy, Elie; Greco, Frank A

Safety and feasibility of concomitant ventral hernia repair and total laparoscopic hysterectomy: A single-centre experience of over 1000 cases

同时行腹壁疝修补术和全腹腔镜子宫切除术的安全性和可行性:单中心1000余例病例经验

Christopher, Pradeep Joshua; Subbiah, Rajapandian; Ramakrishnan, Parthasarathi; Natesan, Anand Vijai; Duraisamy, Kavitha Yogini; Palanivelu, Praveen Raj; Chinnusamy, Palanivelu

Perivascular cells function as key mediators of mechanical and structural changes in vascular capillaries

血管周围细胞是血管毛细血管机械和结构变化的关键介质

Cristiane M Franca, Maria Elisa Lima Verde, Alice Correa Silva-Sousa, Amin Mansoorifar, Avathamsa Athirasala, Ramesh Subbiah, Anthony Tahayeri, Mauricio Sousa, May Anny Fraga, Rahul M Visalakshan, Aaron Doe, Keith Beadle, McKenna Finley, Emilios Dimitriadis, Jennifer Bays, Marina Uroz, Kenneth M Yam

Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers

对布伦妥昔单抗和抗PD-1疗法耐药或不耐受的经典霍奇金淋巴瘤患者的治疗结果:来自15个美国学术中心的真实世界分析

Voorhees, Timothy J; McLaughlin, Eric M; Torka, Pallawi; Florindez, Jorge; Kim, Na Hyun; Moyo, Tamara K; Reves, Heather; Sumransub, Nuttavut; Deshpande, Saarang; Rose, Ashley; Duarte, Cassandra; Faisal, Muhammad Salman; Hamid, Showkat; Subbiah, Suki; Ayyappan, Sabarish; Shea, Lauren; Cortese, Matt; Patel, Krish; Major, Ajay; Saeed, Hayder; Svoboda, Jakub; Desai, Sanjal; Geethakumari, Praveen Ramakrishnan; Hamadani, Mehdi; Grover, Natalie; Epperla, Narendranath

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

在超过 8000 名涵盖 24 种癌症类型的患者中,肿瘤突变负荷与免疫检查点抑制剂治疗后的生存率之间的关系

Gandara, David R; Agarwal, Neeraj; Gupta, Shilpa; Klempner, Samuel J; Andrews, Miles C; Mahipal, Amit; Subbiah, Vivek; Eskander, Ramez N; Carbone, David P; Riess, Jonathan W; Sammons, Sarah; Snider, Jeremy; Bouzit, Lilia; Cho-Phan, Cheryl; Price, Megan; Li, Gerald; Quintanilha, Julia C F; Huang, Richard Sheng Poe; Ross, Jeffrey S; Fabrizio, David; Oxnard, Geoffrey R; Graf, Ryon P

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model

在HT1080肿瘤模型中,Selpercatinib可减轻癌症恶病质,且该作用独立于其抗肿瘤活性。

Khatri, Ujjwol; Gouda, Mohamed A; Pandey, Shriya; Chauhan, Neeraj K; Shen, Tao; Hu, Xueqing; Li, Min; Huang, Suming; Subbiah, Vivek; Wu, Jie

Advancements in Single-Atom Catalysts: Synthesis, Characterization, and Applications in Sensing Technologies

单原子催化剂的研究进展:合成、表征及其在传感技术中的应用

Arivuthilagam, Ilakeya Subbiah; Shahid, Raghisa; Rahman, Md Mahbubur; Lee, Jae-Joon